Quantification of α-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy

被引:209
作者
Rhoades, Elizabeth
Ramlall, Trudy F.
Webb, Watt W.
Eliezer, David
机构
[1] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Program Struct Biol, New York, NY 10021 USA
[3] Cornell Univ, Ithaca, NY USA
关键词
D O I
10.1529/biophysj.105.079251
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
alpha-Synuclein (alpha S) is a soluble synaptic protein that is the major proteinaceous component of insoluble fibrillar Lewy body deposits that are the hallmark of Parkinson's disease. The interaction of aS with synaptic vesicles is thought to be critical both to its normal function as well as to its pathological role in Parkinson's disease. We demonstrate the use of fluorescence correlation spectroscopy as a tool for rapid and quantitative analysis of the binding of alpha S to large unilamellar vesicles of various lipid compositions. We find that aS binds preferentially to vesicles containing acidic lipids, and that this interaction can be blocked by increasing the concentration of NaCl in solution. Negative charge is not the only factor determining binding, as we clearly observe binding to vesicles composed entirely of zwitterionic lipids. Additionally, we find enhanced binding to lipids with less bulky headgroups. Quanti. cation of the protein-to-lipid ratio required for binding to different lipid compositions, combined with other data in the literature, yields an upper bound estimate for the number of lipid molecules required to bind each individual molecule of aS. Our results demonstrate that fluorescence correlation spectroscopy provides a powerful tool for the quantitative characterization of alpha S-lipid interactions.
引用
收藏
页码:4692 / 4700
页数:9
相关论文
共 57 条
[1]   Membrane binding of peptides containing both basic and aromatic residues.: Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS [J].
Arbuzova, A ;
Wang, LB ;
Wang, JY ;
Hangyás-Mihályné, G ;
Murray, D ;
Honig, B ;
McLaughlin, S .
BIOCHEMISTRY, 2000, 39 (33) :10330-10339
[2]   α-synuclein gene triplication discovered in Parkinson's disease [J].
Bradbury, J .
LANCET NEUROLOGY, 2003, 2 (12) :715-715
[3]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[4]   Helix periodicity, topology, and dynamics of membrane-associated α-Synuclein [J].
Bussell, R ;
Ramlall, TF ;
Eliezer, D .
PROTEIN SCIENCE, 2005, 14 (04) :862-872
[5]   Effects of Parkinson's disease-linked mutations on the structure of lipid-associated α-synuclein [J].
Bussell, R ;
Eliezer, D .
BIOCHEMISTRY, 2004, 43 (16) :4810-4818
[6]   A structural and functional role for 11-mer repeats in α-synuclein and other exchangeable lipid binding proteins [J].
Bussell, R ;
Eliezer, D .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 329 (04) :763-778
[7]   MICRODETERMINATION OF PHOSPHORUS [J].
CHEN, PS ;
TORIBARA, TY ;
WARNER, H .
ANALYTICAL CHEMISTRY, 1956, 28 (11) :1756-1758
[8]   The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease [J].
Clayton, DF ;
George, JM .
TRENDS IN NEUROSCIENCES, 1998, 21 (06) :249-254
[9]   Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein [J].
Cole, NB ;
Murphy, DD ;
Grider, T ;
Rueter, S ;
Brasaemle, D ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6344-6352
[10]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576